Information for: Alumni Prospective Students Current Students

Population Aging Research Center

Home
About Us
People
Research
Working Papers
Newsletters
Services
News & Events
Pilot Awards
- Pilot Awards
- Quartet Pilot Project Competition
Training
Allied Centers

NIH Funding Opportunities (Notices, PA, RFA)

Program Officials Are Here to Help
Encouraging Participation in Upcoming NIH Surveys to Identify Impacts of COVID-19 on Extramural Research
Friendlier Approach for Cross-Referencing NOSIs in FOAs Used for Submission
T-21 Days Left Until the NIH Virtual Seminar on Program Funding and Grants Administration
Required Submission of Financial Conflict of Interest Policy into the eRA Commons Institution Profile (IPF) Module
Coccidioidomycosis Collaborative Research Centers (U19 Clinical Trial Not Allowed)
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional)
Notice of Extension to PA-18-350, "NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed)"
Dr. Collins joins 2020 Nobel Laureate in Chemistry Dr. Jennifer Doudna for a conversation on CRISPR, gene editing & more
NIH to launch the Serological Sciences Network for COVID-19, announce grant and contract awardees
NIH clinical trial testing hyperimmune intravenous immunoglobulin plus remdesivir to treat COVID-19 Begins
Notice of Technical Assistance Webinar and Frequently Asked Questions (FAQs) for NHLBI HeartShare RFA-HL-21-015 "Clinical Centers (U01)" and RFA-HL-21-016 "Data Translation Center (U54)"
Notice to Extend the Expiration Date for PAR-18-433 "NIBIB Exploratory/Developmental Research Grant Program (R21 Clinical Trial Optional)"
Notice of Correction to RFA-CA-20-047 Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)"
Notice to Extend the Response Due Date for NOT-DA-20-073 "Request for Information (RFI):Advancing Biomarker Research and Implementation to Personalize Health Services Delivery for Tobacco Use Disorder"
NEI Notice of Participation in PAR-19-093: "Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)"
Utilizing In Vitro Functional Genomics Advances for Gene-Environment (G x E) Discovery and Validation (R01 Clinical Trial Not Allowed)
Notice of NCATS Interest in Receiving Letters Requesting Permission to Submit Applications to Support Annual Microphysiological Systems Scientific Conferences (U13)
Welcome the New RePORT and RePORTER Tools!
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NIH-funded study links adolescent brain differences to increased waist circumference
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
NHGRI researchers work with patients, families and the scientific community to improve the informed consent process
NIH study aims to identify promising COVID-19 treatments for larger clinical trials
Notice of Change to PAR-19-315 "Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)"
Notice of NHLBI Participation in PA-20-227, "Administrative Supplements for Research on Dietary Supplements (Admin Supp Clinical Trial Not Allowed)"
Change of the Award Project Period for PAR-18-950 and PAR-18-951 Opportunities for Collaborative Research at the NIH Clinical Center (X02 and U01)
NIMHD Withdraws Participation in NOT-MH-20-047 "Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus"
NIMHD Withdraws Participation in NOT-MH-20-053 "Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19"
Notice of Change to Budget Information and Key Dates for PAR-20-026, "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01 Clinical Trial Not Allowed)"
Request for Information: Guidance on Current Research on the Prevention of Black Youth Suicide
Notice of Extension to RFA-MH-18-700, "Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01 Clinical Trial Required)"
Notice of Extension to RFA-MH-18-701, "Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)"
Notice of Extension to RFA-MH-18-702, "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33- Clinical Trial Required)"
Notice of Extension to RFA-MH-18-705, "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)"
Notice of Extension to RFA-MH-18-706, "Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required)"
Notice of Extension to RFA-MH-18-707, "Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required"
Notice of Extension to RFA-MH-18-703, "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)"
Notice of Special Interest: Integrative Studies of Neural Mechanisms Underlying Fundamental Affective Processes in Aging
Notice of Extension to RFA-MH-18-704, "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33- Clinical Trial Required)"
Notice of Change to Budget Information and Key Dates for PAR-20-027, "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (Collaborative U01 Clinical Trial Not Allowed)"
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed)
New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center (U24 Clinical Trial Not Allowed)
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
Discovery of Cell-based Chemical Probes for Novel Brain Targets (R21 Clinical Trial Not Allowed)
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional)
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24) (Clinical Trial Optional)
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
From Genomic Association to Causation: A Convergent Neuroscience Approach to Linking Levels of Analysis for Understanding Neuropsychiatric Disorders (U19 Clinical Trial Optional)
Notice to Extend the Response Date for NOT-MH-20-073, "Request for Information (RFI): Fostering Innovative Research to Improve Mental Health Outcomes Among Minority and Health Disparities Populations"
Developing a Culture of Safety in Biomedical Research Training
Notice of Special Interest (NOSI): Administrative Supplements for Minor Alterations and Renovations to Advance Ongoing HIV/AIDS Research Projects Supported by the NIMHD RCMI Program or the NIGMS IDeA and NARCH Programs
Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed)
Notice of Policy Revision: Managing Conflicts of Interest for Requests for Applications (RFAs)
NIH begins large clinical trial to test immune modulators for treatment of COVID-19
Dr. Collins joins Skimm This podcast to discuss COVID-19 vaccine timelines and staying vigilant about COVID-19 safety guidelines
Dr. Collins talks to CNN’s Wolf Blitzer about the recent increase in COVID-19 cases and the importance of wearing a face covering
Dr. Collins speaks with NCATS Dr. Christopher Austin on new NIH clinical trial to test immune modulators for treatment of COVID-19
Notice of Special Interest: Administrative Supplements to Support Dentist Scientists Post Specialty or Residency to Develop Expertise in Dental, Oral and Craniofacial Research
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
NIDDK Research Education Program Utilizing Stimulating Peripheral Activity to Relieve Conditions (SPARC) - Generated Resources (R25 Clinical Trial Not Allowed)
Notice of Change to Key Dates for PAS-18-483 "Promoting Research in Basic Neuroscience (R01 Clinical Trial Not Allowed)"
Notice Announcing Availability of Data Harmonization Tools for Social Determinants of Health (SDOH) via the PhenX Toolkit
Notice of the NIH Office of Disease Preventions Participation in PAR-20-238: Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Notice of the NIH Office of Disease Preventions Participation in PAR-20-214: Research to Improve Native American Health (R21 Clinical Trials Optional)
NIH study tests a comprehensive model intervention to reduce opioid overdose deaths in hard-hit communities
Additional Research Area of Interest for RFA-OH-21-004 "Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)"
Change in Award Budget Ceiling for Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)
Change in Award Budget Ceiling for Commercial Fishing Occupational Safety Training Project Grants (T03)
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
Study discovers gene that helps us know when it’s time to urinate
Brain differences in youth linked to increased waist size
Final report confirms remdesivir benefits for COVID-19
Education programs may improve young children’s asthma control
Notice to Extend the Response Date for NOT-LM-20-015, "Request for Information (RFI): Strategic Opportunities and Challenges for the National Library of Medicine, National Institutes of Health".
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed)
A guest on the Dr. Oz Show, Dr. Collins expresses concern over the colder weather leading to indoor gathering and the rise of COVID-19 cases
Notice of Change to RFA-OD-19-028
BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed)
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)
Pre-Application Webinar for RFA-CA-20-049, New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed) and RFA-CA-20-050, CEECR Coordinating Center (U24 Clinical Trial Not Allowed)
NIH Operates Under a Continuing Resolution
NIH Will Continue to Accept Preliminary Data as Post-Submission Material Through August/October 2021 Councils
Notice of Change of Receipt Date for RFA-HL-21-015 "HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Clinical Centers (U01 Clinical Trial Not Allowed)"
Notice of Change of Receipt Date for RFA-HL-21-016 "HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed)"
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)
Scientists use gene therapy and a novel light-sensing protein to restore vision in mice
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
Share Your Ideas to Foster Research Integrity and the Responsible Conduct of Research
Dr. Collins join’s SiriusXM’s Doctor Radio to provide an update on COVID-19 therapeutics, testing, vaccine development, and more
Notice of Special Interest (NOSI): Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (SBIR/STTR)
Notice of Pre-Application Webinar for RFA-DK-20-021, Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)
Notice of Extension to PA-18-399, "Research on Autism Spectrum Disorders (R03-Clinical Trial Optional)"
Notice of Extension to PA-18-400, "Research on Autism Spectrum Disorders (R21-Clinical Trial Optional)"
Notice of Extension to PA-18-401, "Research on Autism Spectrum Disorders (R01-Clinical Trial Optional)"
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
Exceptions to Use of a Single IRB During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
Notice of Clarification: Policy for Managing Conflict of Interest in NIH Peer Review
Institutions to Submit FCOI Policy Electronically in eRA Commons, Effective November 12, 2020
Automated Trainee Diversity Report Required with RPPRs for Most T, K and Research Education Awards Beginning October 30, 2020
Plant compound reduces cognitive deficits in mouse model of Down syndrome
Dr. Collins addresses children participating in COVID-19 vaccine clinical trials with CNBC’s Shepard Smith
Dr. Collins participates in the National Press Club’s Virtual Newsmaker series
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
Notice of Correction to Earliest Start Date for PAR-20-240 "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)"
Notice of Change to PA-20-208, "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Optional)"
Notice of Special Interest (NOSI): Use of Predictive Analytics to Accelerate Late-Stage Implementation Research to Address Heart, Lung, Blood, and Sleep Disorders
Study sheds light on key steps in the HIV life cycle
How your body senses the urge to urinate
Higher calorie treatment for people hospitalized with anorexia
Notice of Intent to Publish a Funding Opportunity Announcement for Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite (UG3/UH3) with Coordinating Center (U24)
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and Stroke (R25 - Clinical Trial Not Allowed)
AHRQ Grantees - Upcoming Mandatory Submission of the Federal Financial Report (FFR) via the Payment Management System Beginning January 1, 2021
Notice of Special Interest: Competitive Supplements for Implementation Science Research as Part of NHLBI-funded Phased Awards (R61/R33 and UG3/UH3)
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
NIA Intervention Testing Program (ITP) Announces Annual Call for Compounds to Test for Anti-Aging Activity in Mice
Postpartum depression may persist three years after giving birth
Pre-Application Webinar for RFA-ES-20-007, Pediatric and Reproductive Environmental Health Scholars program (K12 Independent Clinical Trial Not Allowed)
Scientists use clues in the human genome to discover new inflammatory syndrome
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed)
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required)
Notice of Intent to Publish a Funding Opportunity Announcement for NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15 Clinical Trial Not Allowed)
Treatments for Lewy Body Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required)
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco Regulatory Science (R01 Clinical Trial Optional)
Request for Information (RFI): Inviting Comments and Suggestions on the NIH-Wide Strategic Plan for COVID-19 Research
NIH scientists discover key pathway in lysosomes that coronaviruses use to exit cells
Supplemental Information to the NIH Policy for Data Management and Sharing: Selecting a Repository for Data Resulting from NIH-Supported Research
Supplemental Information to the NIH Policy for Data Management and Sharing: Allowable Costs for Data Management and Sharing
Supplemental Information to the NIH Policy for Data Management and Sharing: Elements of an NIH Data Management and Sharing Plan
Final NIH Policy for Data Management and Sharing
Seeking Your Ideas on the NIH-Wide Strategic Plan for COVID-19 Research
Notice Regarding New Receipt Date for Revision Applications for PAR-15-352: "Occupational Safety and Health Training Project Grants (T03)"
Notice of Change to PAR-18-427, "First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)"
Researchers, if You Received a Survey, Please Provide Us with Your Perspective on the Impact of COVID-19
Statement on Final NIH Policy for Data Management and Sharing
“All About Grants” Podcast – Human Subjects’ Protection and Monitoring Plans
NIH Releases New Policy for Data Management and Sharing
Drs. Collins and Fauci provide an update on COVID-19 vaccine research during a Facebook and Twitter live event
How Can I Monitor Institutional Compliance With NIH’s Public Access Policy?
Notice of Change: Expansion of Research Scope of NOT-OD-20-049 "Notice of Special Interest: Administrative Supplements for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)"
Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) (UT2 - Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Improving Health Disparities in Alcohol Health Services (R01 Clinical Trial Optional)
Exceptions to Use of a Single IRB During the COVID-19 Public Health Emergency
Gene therapy with novel protein restores vision in mice
How mucus in the colon prevents inflammation and injury
New inflammatory disease discovered
November 11 (Wednesday), 2020: NIH Closed for the Federal Holiday
November 26 (Thursday), 2020: NIH Closed for the Federal Holiday
Neighborhood conditions associated with children’s cognitive function
Notice of Special Interest (NOSI): Availability of Administrative Supplements to Adapt/Repackage Visualization Methods for Enhancing Cancer Moonshot Data
Pre-Application Webinar for NOT-CA-21-008, Notice of Special Interest (NOSI): Availability of Administrative Supplements to Adapt/Repackage Visualization Methods for Enhancing Cancer Moonshot Data
Presolicitation Notice: Request for Proposals (RFP) 75N91021R00007 "Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients"
Presolicitation Notice: Request for Proposals (RFP) 75N91021R00003 "Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications"
Presolicitation Notice: Request for Proposals (RFP) 75N91021R00004"Preclinical Toxicology of Large Molecule Drugs Developed for Cancer and Other Indications"
Pre-Application Webinar for RFA-CA-20-043 "Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed) "
Extended Guidance for Applicants Preparing Applications During the COVID-19 Pandemic
Did You Miss the 2020 NIH Virtual Seminar on Program Funding and Grants Administration?
Notice of Extension of the Expiration Date for PAR-18-530 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)"
Notice to Extend the Expiration Date for PAR-18-656, NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Continued Impact of COVID-19 on Biomedical Research
AHRQ Guide Notice on Exception to the Use of the Single IRB Review Requirements During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required)
Notice of Correction to Specific Areas of Research Interest for PAR-20-168 "Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed)"
Notice of Office of Laboratory Animal Welfare Statement on Oversight of NIH-owned Chimpanzees
NIA Withdraws Participation in NOT-AG-20-022 - NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
The NIH Office of Disease Prevention (ODP) Announces the Pathways to Prevention Workshop: Can Physical Activity Improve the Health of Wheelchair Users?
Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional)
Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional)
The gut trains the immune system to protect the brain
NIH researchers identify gene in mice that controls food cravings, desire to exercise
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33)
Notice of Extension of the Expiration Date for PAR-18-885 Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed)
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required)
Notice to Extend the Expiration Date for PAR-18-547, NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Introducing the Stephen I. Katz Early Stage Investigator Research Grant Program
NIH study finds long-acting injectable drug prevents HIV acquisition in cisgender women
Hydroxychloroquine does not benefit adults hospitalized with COVID-19
Coronaviruses hijack lysosomes to exit cells
Postpartum depression may last for years
Rural youth often lack access to suicide prevention services
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Notice of NCI's Withdrawal from Participation in PAR-19-064, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"
Notice of NIDDK Participation in PA-20-190 and PA-20-191, NIH Mentored Research Scientist Development Award (Parent K01 Independent Clinical Trial Required and No Independent Clinical Trial Not Allowed) Funding Opportunity Announcements
Notice of Correction in Key Dates for NIDA PAR-21-044, " Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)"
Notice of Extension of the Expiration Date for PAR-18-884 Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed)
Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects
Notice of Special Interest (NOSI): Administrative Supplement for Providing Travel Support for Awardees to Attend the Annual NIH Synthetic Biology Consortium Meeting (Admin Supp)
NIH calls on clinical researchers to swiftly share COVID-19 results
Dr. Collins and Bill & Melinda Gates Foundation’s Dr. Chris Karp perform “In Our Lives”
Treatments for people with early COVID-19 infection is an urgent research focus
Notice of Intent to Publish a Funding Opportunity Announcement for Nutrition for Precision Health, powered by the All of Us Research Program: Artificial Intelligence for Multimodal Data Modeling and Bioinformatics Center (U54 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Nutrition for Precision Health, powered by the All of Us Research Program: Microbiome and Metagenomics Center (U24 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Nutrition for Precision Health, powered by the All of Us Research Program: Metabolomics and Clinical Assays Center (U24)
Notice of Intent to Publish a Funding Opportunity Announcement for Nutrition for Precision Health, powered by the All of Us Research Program: Dietary Assessment Center (U24 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Nutrition for Precision Health, powered by the All of Us Research Program: Clinical Centers (UG1 Clinical Trial Required)
Notice of Intent to Publish a Funding Opportunity Announcement for Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Notice of Participation of the National Institute on Drug Abuse(NIDA) in RFA-MD-21-002, "Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required)"
Notice of NINR Participation in NOT-HL-20-737 Notice of Special Interest (NOSI): Palliative Care in Heart, Lung, Blood, and Sleep Diseases
NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
Notice of Participation of the National Institute on Drug Abuse(NIDA) in PA-19-050, "Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)"
Notice of Correction to NOT-OD-21-012 "Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco Regulatory Science (R01 Clinical Trial Optional)"
Notice of Change: Correction of Eligibility Information for RFA-AI-20-056 Coccidioidomycosis Collaborative Research Centers (U19 Clinical Trial Not Allowed)
Notice of Participation of the National Institute on Drug Abuse(NIDA) in RFA-MD-21-001, "Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional)"
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional)
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional)
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional)
Notice of Participation of the National Institute on Drug Abuse(NIDA) in PA-19-042, "Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)"
NOSI: Academy of Finland (AKA) National Institutes of Health (NIH) Partnership Program
Technical and Business Assistance (TABA) Needs Assessment Program for National Institutes of Health (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees
Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 - Clinical Trial Not Allowed)
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
Understanding the Cellular and Molecular Mechanisms of Gastroparesis in Adults and Children (R01 Clinical Trial Not Allowed)
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
NIAAA Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)
Cardiac arrest treatment that uses life support machine boosts survival
Dr. Collins speaks to MSNBC’s Ali Velshi about the potential timeline for the approval, manufacturing and distribution of one or more COVID-19 vaccines
Exploratory Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Optional)
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations with the NCI-supported PDX Development and Trial Centers Research Network (PDXNet)
Notice of NIA Withdrawal from Participation in NOT-MD-20-019 "Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities"
Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine
Notice of NIA Withdrawal from Participation in NOT-MH-20-047 "Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus"
Notice of NIA Withdrawal from Participation in NOT-OD-20-097 "Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Soc
Notice of NIA Withdrawal from Participation in NOT-MH-20-053, "Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19"
Notice of NIA Withdrawal from Participation in NOT-MD-20-022, "Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations"
Dr. Collins joins PBS NewsHour to discuss interim results of the NIH-Modera vaccine trial
Envision color: Activity patterns in the brain are specific to the color you see
NIH Challenges Academia to Share Strategies to Strengthen Gender Diversity
Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R01 Clinical Trial Optional)
Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R34 Clinical Trial Optional)
Notice of Extension of the Expiration Date of PAR-18-771 "NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)"
Temporary Extension of Eligibility for the NIDDK K01 Mentored Research Scientist Development Award During the COVID-19 Pandemic
Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities
NIH Implementation of the Revised Federal-wide Research Terms and Conditions
Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed)
Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)
Notice of Change: Corrected Application Forms and Extension of Application Due Date for RFA-RM-20-016, Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Training Program (U2R Clinical Trial Optional)
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed)
Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
NIH to fund research of racial disparities in pregnancy-related complications and deaths
NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required)
NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required)
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
Notice of Extension to PAR-18-554, "Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional)"
Notice of Extension to PAR-18-555, "Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional)"
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Notice of Clarification to NIEHS' Participation on PA-20-272, "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)"
“All About Grants” Podcast – Alternatives to Animals
Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional)
Notice of Extension of the Expiration Date of PAR-18-772 "NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)"
Dr. Collins discusses the COVID-19 vaccine development timeline with Fox News’ Martha MacCallum
Biological Testing Facility (X01 Clinical Trial Not Allowed)
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
Should We Keep Meeting This Way?
Contraceptive Development Research Centers Program (P50 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Cellular Cancer Biology Imaging Research (CCBIR) Program (U54 Clinical Trial Not Allowed)
Diabetes Research Centers (P30 Clinical Trial Optional)
Outstanding New Environmental Scientist (ONES) Award (R01 Clinical Trial Optional)
Dr. Collins is the featured speaker for the Association of Health Care Journalists’ 2020 Journalism Summit on Infectious Disease
Study of “exceptional responders” yields clues to cancer and potential treatments
New NIH BRAIN Initiative awards move toward solving brain disorders
Initiative for Maximizing Student Development (IMSD) (T32 - Clinical Trial Not Allowed)
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Pre-Application Webinar for RFA-CA-20-054, Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed)
Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed)
NIH expands research to improve COVID-19 testing among underserved and vulnerable populations
Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
Small Vessel VCID Biomarker Validation Consortium Sites (U01)(Clinical Trials Not Allowed)
Prohibition on Expending NIH Grant Funds for Covered Telecommunications Equipment or Services
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
Notice of Clarification of SB1 Resubmission/Submission Policy
Notice of Change: Clarification of Page Limits for RFA-EY-20-001 "NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed)"
GenitoUrinary Development Molecular Anatomy Project (GUDMAP) - Atlas Projects (U01 Clinical Trial Not Allowed)
Reconfiguration of GenitoUrinary Development Molecular Anatomy Project (GUDMAP) /(Re)Building A Kidney (RBK) Data Hub (U24 Clinical Trial Not Allowed)
Notice Extending Expiration Date and Adding Receipt Date for PAR-18-307: Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)
Notice Extending Expiration Date and Adding Receipt Date for PAR-18-324: Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
Notice of Intent to Reissue Funding Opportunity Announcements "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)" to Permit Resubmissions
Request for Information (RFI) Regarding Opportunities for New National Programs at the National Cancer Institutes (NCI) Frederick National Laboratory for Cancer Research
Decades of NIH research help lead to first FDA-approved treatment for progeria
Immune cells trained in the gut protect the brain
Life support machine helps cardiac arrest patients survive
Hydroxychloroquine doesn’t benefit hospitalized COVID-19 patients
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed)
Notice of Clarification to NIEHS' Participation on PA-21-071, "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)"
Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science
Commonly used antibiotic shows promise for combating Zika infections
Notice of Expiration of PAR-19-370 NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad)
Rollout of Redesigned eRA Commons Home and Landing Screens in January 2021
Notice of Removal of Cost Matching Requirements for RFA-NS-21-010 "HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)"
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)
Fourth iteration of COVID-19 treatment trial underway
Notice of Special Interest: Advances in Research for the Treatment, Services, and Recovery of Alcohol Use Disorder
In an MSNBC interview with Ali Velshi, Dr. Collins addresses COVID-19 vaccine hesitancy and the safety and efficacy standards for FDA approval
Summer Institute for Research Education in Biostatistics and Data Science (R25 Clinical Trial Not Allowed)
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trials Not Allowed)
Experimental Vaccine for Deadly Tickborne Virus Effective in Cynomolgus Macaques
NIH announces restructured HIV clinical trials networks
Notice to Extend NCCIH's PA-18-323, "Fundamental Science Research on Mind and Body Approaches (R01 Clinical Trial Optional)"
Notice to Extend NCCIH's PA-18-322, "Funding Opportunity Title Fundamental Science Research on Mind and Body Approaches (R21 Clinical Trial Optional)"
New Human Research Protection Training Available!
Extended Guidance for Applicants Preparing Applications During the COVID-19 Pandemic
NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
NIH Statement on World AIDS Day 2020
NHLBI Program Project Applications (P01 Clinical Trials Optional)
Notice to Extend Expiration Date for PAR-19-133 "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)"
Notice of NICHD Participation on PA-20-194 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)"
Notice of NICHD Participation on PA-20-200 "NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)"
Notice of NICHD Participation on PA-20-195 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)"
NICHD Data and Safety Monitoring Guidelines for Extramural Clinical Trials and Clinical Research
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)
Check Out the New eRA Commons Screens!
Notice of NIDDK Participation in PAR-20-238, Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Notice of Special Interest: Kidney Precision Medicine Technology Development and Translation
Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21)
Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01)
December 25 (Friday), 2020: NIH Closed for the Federal Holiday
New FAQs on Policy for Charging PPE to NIH Grants & Cooperative Agreements (NOT-OD-20-164)
Federal Financial Report (FFR) Required to be Submitted in the Payment Management System, Effective January 1, 2021
January 1 (Friday), 2021: NIH Closed for the Federal Holiday
Reminder to AHRQ Grantees that FY2016 Funds will Expire on September 30, 2021
Notice of Special Interest (NOSI): High-throughput Molecular and Cellular Phenotyping
New updates to federal guidelines revamp asthma management
Dr. Collins discusses a range of COVID-19 vaccine-related topics with Russell Moore, president of the Southern Baptist Convention's Ethics and Religious Liberty Commission
Updated Instructions on Interim Reporting and Carryover for RADx-UP Recipients
Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application
REMINDER - Expiring Funds Alert to AHRQ Grant Recipients who Received Multi-Year Funded Awards
NIH researchers link cases of ALS and FTD to a mutation associated with Huntington’s disease
High-dose influenza vaccine shows no additional benefit for heart disease patients
Notice of Early Expiration of PAR-20-039 "Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)"
Notice of Early Expiration of PAR-20-040 "Support of Competitive Research (SCORE) Pilot Project Award (SC2 Clinical Trial Not Allowed)"
Notice of Early Expiration of PAR-20-041 "Support of Competitive Research (SCORE) Research Continuance Award (SC3 Clinical Trial Not Allowed)"
Notice of Addition of AIDS Application Due Dates to PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)"
NICHD Adverse Event, Unanticipated Problem, and Serious Adverse Event Reporting Guidance
Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
Notice of Intent to Publish a Funding Opportunity Announcement for Support for Research Excellence (SuRE)
Notice of Intent to Publish a Funding Opportunity Announcement for Support for Research Excellence - First Independent Research Support and Transition (SuRE-First)
Notice of Intent to Publish a Funding Opportunity Announcement for a National Resource Center for the Support for Research Excellence (SuRE) Program
Notice of Intent to Publish the Reissuance of Building Interdisciplinary Research Careers in Women's Health Program (K12 Clinical Trial Optional)
On NPR Morning Edition, Dr. Collins details the next steps in order for FDA to grant Emergency Use Authorization for COVID-19 vaccine candidates
NIH-funded tool helps organizations plan COVID-19 testing
Understanding “exceptional responders” to cancer treatment
Molecule guides stem cells to damaged brain tissue
Hormone suppresses hunger in primates and people
Notice of NINDS Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
Notice of Correction to the Expiration Date of RFA-MH-21-140 "BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed)"
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Basic Experimental Studies with Humans Required)
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required)
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 No Independent Clinical Trials)
NEI Notice of Participation in PA-20-202, "Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)"
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed)
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)
NEI Notice of Participation in PA-20-206, "Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)"
Notice of Intent to Publish a Funding Opportunity Announcement: Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health
Dr. Collins joins Bill Nye on the Science Rules! podcast to discuss the science behind COVID-19 vaccines and therapeutics
NIH to fund cohort recruitment and development program to enhance diversity and inclusion among biomedical faculty
NIAMS Centers of Research Translation (CORT) (P50 - Clinical Trial Not Allowed)
Notice of Change to the Number of Applications that Can Be Submitted by Institutions Applying to PAR-21-025 "Initiative for Maximizing Student Development (IMSD) (T32 - Clinical Trial Not Allowed)"
Notice of Change to the Number of Applications that Can Be Submitted by Institutions Applying to PAR-21-026 "Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed)"
Notice of Extension of the Expiration Date for PAR-18-578 "Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional)"
Research Experiences in Genomic Research for Data Scientists (R25)
Notice of Pre-Application Webinar for RFA-DK-20-023, Toward ElucidAting MechanismS Contributing to HIV Reservoirs in NIDDK-relevant Tissues (Cure TEAMS) (R01 Clinical Trial Optional)
Mentored Research Experiences for Genetic Counselors (R25)
Findings of Research Misconduct
Cellular Cancer Biology Imaging Research (CCBIR) Program (U54, Clinical Trial Not Allowed)
Mood Disorders in People Living with HIV: Mechanisms and Pathways (R01 Clinical Trial Optional)
Mood Disorders in People Living with HIV: Mechanisms and Pathways (R21 Clinical Trial Optional)
Notice of Clarification of Award Budget Instructions for the Opportunity Pool within RFA-DK-20-014, Reconfiguration of GenitoUrinary Development Molecular Anatomy Project (GUDMAP) /(Re)Building A Kidney (RBK) Data Hub (U24 Clinical Trial Not Allowed)
Notice of Pre-Application Webinar for RFA-DK-20-022, Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
Some postmenopausal women with common breast cancer may forgo chemotherapy
Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed)
Virtual Approaches Towards New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (U18 Clinical Trials Not Allowed)
New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed)
Notice of Special Interest (NOSI): Urgent Competitive Revisions for Research on Critical Threats to Public Health in Large-Scale Population Cohorts
Some Thoughts Following the NIH Inclusion Across the Lifespan 2 Workshop
Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing Access to Research Careers (T34 Clinical Trial Not Allowed)
Notice of Change in Scientific/Research Contact for PAR-20-304, "Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)".
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R43 Clinical Trial Not Allowed)
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R41 Clinical Trial Not Allowed)
Dr. Collins is featured in an ABC News story on vaccine hesitancy
NIH’s All of Us Research Program returns first genetic results to participants
NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
Required Use of Two-Factor Authentication Using Login.Gov for eRA's External Modules in 2021
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
Notice of Informational Webinar for RFA-CA-20-055, RFA-CA-20-056, and RFA-CA-20-057: "Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00)"
Notice of Special Interest (NOSI): Tailoring Follow-up Care for Survivors Using Risk-Stratified Pathways
Notice of Pre-Application Webinar for the NCI-CRUK Cancer Grand Challenges
Guidance on Page Limits for Specific Aims for Fundamental-Plus or Expanded applications for PAR-20-312, NIOSH State Occupational Safety and Health Surveillance Program (U60)
Clarification on Prohibition on Expending NIH Grant Funds for Covered Telecommunications Equipment or Services
Baricitinib plus remdesivir shows promise for treating COVID-19
In an interview with ABC News’ Linsey Davis, Dr. Collins comments on the Pfizer COVID-19 vaccine trial results and data
In a Q&A with Washington Post’s Sarah Pulliam Bailey, Dr. Collins shares his views on the intersection of faith and science and the COVID-19 pandemic
Dr. Collins speaks to Fox News’ Martha MacCallum about FDA’s review of the Pfizer COVID-19 vaccine
On Sunday’s Meet the Press, Dr. Collins addresses vaccine skepticism and concerns over the speed of COVID-19 vaccine development
Limited Competition: National Institute on Aging (NIA) Late Onset of Alzheimers Disease (LOAD) Family-Based Study (FBS) (U24 Clinical Trial Not Allowed)
New OLAW Webinar: Developments in FOIA in the Context of Animal Research
NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32)
Engaging the dental workforce to end the HIV epidemic in the U.S. (UG3/UH3 Clinical Trial Required)
Stress may awaken dormant cancer cells
Financial problems can be sign of dementia onset
Antibodies and T cells protect against SARS-CoV-2
Notice of NCATS Withdrawal from Participation in PAR-20-243, "Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)"
Notice of Special Interest (NOSI): Sensory and Motor System Changes as Predictors of Preclinical Alzheimers Disease
Notice of Changed Application Forms for RFA-CA-20-049 "New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed)"
Notice of Change to Award Budget for PHS 2020-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
eRA Will Require the Use of Login.gov to Access eRA Commons, ASSIST, IAR and Commons Mobile in 2021
Surgical and drug treatment options lead to similar outcomes for diabetic eye disease
A feature in the Guardian highlights Dr. Collins’s efforts to bring the public and private sector together to rapidly develop diagnostics, treatments and vaccines for COVID-19
Study finds surge of teen vaping levels off, but remains high in early 2020
NIH-funded COVID-19 home test is first to receive over-the-counter authorization from FDA
Notice of Special Interest (NOSI): Discovery of the Genetic Basis of Conditions Associated with Down Syndrome for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project (X01)
NIH observational study of coronavirus infection and multisystem inflammatory syndrome in children begins
Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
Pre Solicitation Notice: Clinical Pharmacology Quality Assurance (CPQA) Program, RFP: 75N93021R00003
Notice of Clarification to Career Stages Supported for PAR-20-240 "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)"
Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs
Notice of Change of Key Dates for RFA-HD-22-003 "Contraception Development Research Center Program (P50 Clinical Trial Optional)"
Notice of NCATS Withdrawal from Participation in PAR-20-165, "Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed)"
Notice of NCATS Withdrawal from Participation in PAR-20-168, "Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed)"
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
NIH researchers discover brain area crucial for recognizing visual events
Cataract surgery in infancy increases glaucoma risk
Investigational COVID-19 therapeutics to be evaluated in large clinical trials
AHRQ Notice of Extension of PA-18-793
Notice of Special Interest (NOSI) regarding the Use of Human Connectome Data for Secondary Analysis
Case Study in Review Integrity: Sharing an Application Being Reviewed
CBS News’ Jon LaPook talks to Dr. Collins about NIH’s efforts to address and overcome vaccine hesitancy
Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine
Notice of Extension to PA-18-579, "Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R41/R42 - Clinical Trial Optional)"
Notice of Extension to PA-18-567,"Competing Renewal Awards of SBIR Phase IIB Grants for Brain and Behavior Tools (R44-Clinical Trial Optional)"
Notice of Extension to PA-18-819, "Lab to Marketplace: Tools for Brain and Behavioral Research (R43/R44 Clinical Trial Optional)"
Notice of Change to Budget Information and Key Dates for PAR-20-027, "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (Collaborative U01 Clinical Trial Not Allowed)"
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)
Notice of Cancellation of May 25, 2021 submission date for PAR-20-076 "Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI) for the NEI Anterior Segment Initiative (ASI): Identification and Development of New Biomarkers and Effective methods to Diagnose Dry Eye Disease.
Notice of Change to Key Dates for PAR-18-304 "NIH SIREN Neurologic Clinical Trials (U01 Clinical Trial Required)"
Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Support Global Cancer Stigma Research
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
Notice to Extend Expiration Date for PA-18-480 "NICHD Research Project Grant (R01 - Clinical Trial Required)"
Notice to Extend Expiration Date for PA-18-481 "NICHD Small Grant Program (R03 Clinical Trial Optional)"
Notice of Extension to PA-18-566, "Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R43/R44 Clinical Trial Optional)"
Notice of Extension to PAR-18-430, "Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)"
NIH to support radical approaches to nationwide COVID-19 testing and surveillance
NIH funds eight studies to uncover risk factors for COVID-19-related inflammatory syndrome in children
Reston Ebolavirus spreads efficiently in pigs
NIH holds COVID-19 vaccine kick-off event
2020 Research Highlights — Basic Research Insights
2020 Research Highlights — Promising Medical Findings
2020 Research Highlights — Human Health Advances
New eRA Commons Screens Are Almost Here!
Notice of Correction to NOT-OD-21-020 Application and Submission Information
Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
NIH neuroscientists isolate promising mini antibodies against COVID-19 from a llama
Dr. Collins joins MSNBC after receiving his COVID-19 vaccine and speaks to Chris Jansing about vaccine skepticism
Dr. Collins talks to CNBC’s Shepard Smith about receiving the COVID-19 vaccine and what to expect with developing, manufacturing and distributing doses in 2021
Pregnant women in third trimester unlikely to pass SARS-CoV-2 infection to newborns
NIH ACTIV Trial of blood thinners pauses enrollment of critically ill COVID-19 patients
Infant opioid withdrawal therapy varies widely by treatment site
Results of NIH-sponsored ACTIV-3 trial published
Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional)
Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional)
Notice of Correction to PAR-21-081 "Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)" Standard Due Dates Apply
Dr. Collins is among health experts asked by WebMD to share public and personal lessons from the COVID-19 pandemic
Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R41/R42 - Clinical Trials Optional)
Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R43/R44 - Clinical Trials Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
NIDDK Investigator-Initiated Multi-Center Clinical Studies Revised Guidance
Notice of NIDDK Participation in PA-20-183, Research Project Grant (Parent R01 Clinical Trial Required)
Notice of NIDDK Participation in PA-20-184, Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research
Notice of Special Interest (NOSI) regarding the Use of Human Connectome Data for Secondary Analysis
AI-designed serotonin sensor may help scientists study sleep and mental health
Scientists discover how our brains track where we and others go
Dr. Collins is among health experts asked by WebMD to share public and personal lessons from the COVID-19 pandemic
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 - Clinical Trials Not Allowed)
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 - Clinical Trials Not Allowed)
Notice of Special Interest (NOSI): Adopting Techniques and Tools Developed from the BRAIN Initiative Toward NIMH Strategic Research Priorities
Improving Health Disparities in Alcohol Health Services (R01 Clinical Trial Optional)
Study links metabolic syndrome to higher cardiovascular risk in patients with psoriasis
Phase 3 trial of Novavax investigational COVID-19 vaccine opens
Notice of Participation of NIMH in PAR-20-300, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)"
Reminder: Mandatory Submission of the Federal Financial Report (FFR) in the Payment Management System Beginning January 1, 2021
Findings of Research Misconduct
Higher red cell transfusion threshold offers no advantage for treating preterm infants
NIH study uncovers blood vessel damage and inflammation in COVID-19 patients’ brains but no infection
Peer-reviewed report on Moderna COVID-19 vaccine publishes
Dr. Collins coauthors a Perspective in the New England Journal of Medicine on the progress of genomics research
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed)
Notice of NIH Participation in the National Science Foundation Enabling Discovery through GEnomics (EDGE) Program
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed
International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)
Reflections on 2020, Looking Towards 2021
Notice of Special Interest (NOSI): Leveraging Population-based Cancer Registry Data to Study Health Disparities
Notice of Special Interest: Alcohol-induced Tissue-specific and Organ System Diseases (R01/R21/R03)
Notice of Special Interest (NOSI): Innovative Molecular Analysis Technologies for Low-Resource Settings Globally
AHRQ Notice of Extension of PA-17-007
All About Grants Podcast: Human Subjects’ Research Post-Award
Request for Information (RFI): Inviting Comments and Suggestions on the Surgeon-Scientist effort requirement on K08 awards from the National Cancer Institute
Findings of Research Misconduct
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19
Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01 Clinical Trial Optional)
Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required)
Next Generation Sequencing in Post Mortem Tissue from Patients with Parkinsons Disease (U01 Clinical Trial Not Allowed)
Notice to Extend the Expiration Date for PAR-18-580 "Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 Clinical Trial Optional)"
January 18 (Monday), 2021: NIH Closed for the Federal Holiday
January 20 (Wednesday), 2021: NIH Closed for the Federal Holiday
Explore RePORTER’s State Map Visualizations
Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed)
Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed)
Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed)
Dr. Collins participates in a Washington Post Live interview with Frances Stead Sellers on combatting COVID-19
DNA-editing method shows promise to treat mouse model of progeria
Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed)
Limited Competition: Revision to the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
Stem cell treatment corrects skull shape and restores brain function in mouse model of childhood disorder
Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)
Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)
Clarification of Scientific Overlap Concerns in PAR-19-367 "Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)"
Notice of NIMHD Participation in the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) Program
Notice of NIMHD Participation in PA-21-049 and PA-21-050, Announcements for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowships for Students in Predoctoral Dual-Degree Training Programs (Parent F30)
Notice to Extend Expiration Date for PAR-19-362: Planning Grant for Global Infectious Disease Research Training Program (D71 - Clinical Trials Not Allowed)
NHGRI Notice of Participation in PAR-19-134, "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)"
Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed)
Statement on the establishment of the Office of Nutrition Research within the NIH Office of the Director
HEAL Initiative: Data Coordinating Center for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (U24 Clinical Trial Required)
HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial - Clinical Sites (UG1 Clinical Trial Required)
HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed)
HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed)
Notice to Extend the Response Date for NOT-CA-21-018 "Request for Information (RFI) Regarding Opportunities for New National Programs at the National Cancer Institutes (NCI) Frederick National Laboratory for Cancer Research"
HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24)
HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed)
HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Coordination and Dissemination Center (R24 Clinical Trial Optional)
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)
Clarification of Scientific Overlap Concerns in PAR-20-117 "Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional)"
Notice of Change to Funding Opportunity Description to Clarify the Requirement for a Sustainability Plan in PAR-20-104 "Biomedical Technology Development and Dissemination Center (RM1 - Clinical Trial Not Allowed)"
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the NIDDK (R21 Clinical Trial Not Allowed)
In Broad Institute video, Dr. Collins describes new study using gene base editing to treat progeria
Physician-pharmacist collaboration may increase adherence to opioid addiction treatment
Dr. Collins joins Senator Bill Frist’s podcast A Second Opinion to discuss the Human Genome Project, COVID-19 vaccine development, and more
NIH study suggests using cannabis while trying to conceive may reduce pregnancy chances
Experimental coronavirus vaccine highly effective
How the human brain tracks location
Nanoparticles developed for traumatic brain injury
Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)
Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)
Notice of Change to Funds Available and Anticipated Number of Awards for RFA-MH-21-140, "BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed)"
Notice of Pre-Application Webinar for Cellular Senescence Network (SenNet) RFAs: RFA-RM-21-008, RFA-RM-21-009, RFA-RM-21-010
Salary Limitation on AHRQ FY2021 Grants, Cooperative Agreements, and Contracts
Dr. Collins joins the Stetzer Leadership Podcast to discuss the role the faith community can play in fighting the COVID-19 pandemic
Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed)
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
Notice of NICHD Participation on PA-20-196 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)"
Blood test shows promise for early detection of acute heart transplant rejection
Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for RFA-DA-21-029, RFA-DA-21-030, and RFA-MH-21-145
Reminder: NIH Will Continue to Accept Preliminary Data as Post-Submission Material Through August/October 2021 Councils
INTUIT-PC: Improving Nonsurgical Treatment of Urinary Incontinence among women in Primary Care: Dissemination and Implementation of PCOR Evidence (U18)
NIH scientists study salmonella swimming behavior as clues to infection
Combination treatment for methamphetamine use disorder shows promise in NIH study
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
Notice of Technical Assistance Webinar for NHLBI Hope for Sickle Cell Disease Challenge
Request for Information (RFI): Inviting Comments and Suggestions on the Identification of Key Events in Autoimmune Diseases
Notice of Special Interest (NOSI): KC Donnelly Externship (Admin Supp Clinical Trial Not Allowed)
NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed)
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required)
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required)
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional)
Request for Information (RFI): Solicitation of Input on Common Data Elements for Lower Limb Loss Research Standards
Notice of Special Interest (NOSI): Biophysical and Biomechanical Aspects of Embryonic Development (R21)
Notice of Special Interest (NOSI): Administrative Supplements for NCI Division of Cancer Biology Research Programs
Infectious Etiology of Alzheimer's Disease (R01 Clinical Trial Optional)
BRAIN Initiative: Request for Information (RFI) on Development and Dissemination of Human Brain Imaging Technologies
Dr. Collins joins National Association of Evangelicals President Walter Kim on the Today’s Conversations podcast to discuss COVID-19 vaccines and the faith community.
NIH scientists identify nutrient that helps prevent bacterial infection
On NPR’s All Things Considered, Dr. Collins provides an update on the state of COVID-19 vaccines in the U.S.
Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
What You Read in 2020
NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required)
NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Clinical Trial Not Allowed)
NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required)
Check Out NIH’s New COVID-19 Research Website
Timing is of the essence when treating brain swelling in mice
Nutrition for Precision Health, powered by the All of Us Research Program: Metabolomics and Clinical Assays Center (U24 Clinical Trial Not Allowed)
Nutrition for Precision Health, powered by the All of Us Research Program: Microbiome and Metagenomics Center (U24 Clinical Trial Not Allowed)
Nutrition for Precision Health, powered by the All of Us Research Program: Dietary Assessment Center (U24 Clinical Trial Optional)
Nutrition for Precision Health, powered by the All of Us Research Program: Artificial Intelligence for Multimodal Data Modeling and Bioinformatics Center (U54 Clinical Trial Not Allowed)
Nutrition for Precision Health, powered by the All of Us Research Program: Clinical Centers (UG1 Clinical Trial Required)
Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center (U24 Clinical Trial Not Allowed)
Notice of Change in Key Dates for PAR-20-289, NIAID Research Education Program (R25 Clinical Trial Not Allowed)
Notice of Correction to Earliest Start Date for PAR-21-038 and PAR-21-039 - Stephen I. Katz Early Stage Investigator Research Project Grant
Methamphetamine overdose deaths rise sharply nationwide
NIH researchers identify new genetic disorder that affects brain, craniofacial skeleton
NIH study compares low-fat, plant-based diet to low-carb, animal-based diet
Updated Guidelines for Enhancing Diversity and Creating Safe Environments in Conferences Supported by NIH Grants and Cooperative Agreements
Notice of Special Interest (NOSI): Promoting Research on Interoception and Its Impact on Health and Disease
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)
Notice of Information Regarding NIGMS Changes to Candidate and Activity Code Eligibility for PA-21-071 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
Enhancing Diversity at NIH-Funded Conferences
Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients
Notice of Termination of RFA-TR-20-030 "Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
Notice of Change to Key Dates for Cellular Senescence Network (SenNet) RFA-RM-21-008 "Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed)"
Notice of Change to Key Dates for RFA-RM-21-009 "Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed)"
NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed)
Notice of Change to Key Dates for RFA-RM-21-010 "Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed)"
Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for RFA-DA-21-020, RFA-DA-21-021, RFA-DA-21-022, and RFA-DA-21-023
Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers
Notice of Pre-Application Webinar for the Common Funds Nutrition for Precision Health Program RFAs.
Low-dose aspirin may improve pregnancy chances for women with one or two prior miscarriages
Physician-pharmacist collaboration may improve care for opioid addiction
Acute heart transplant rejection detected earlier with new test
Lasting immunity found after recovery from COVID-19
NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed)
Notice of NIDA's Participation in NOT- MD-21-008 "Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities"
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19)
Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)
Antibody infusions prevent acquisition of some HIV strains, NIH studies find
NIH launches database to track neurological symptoms associated with COVID-19
Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes
Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trials Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed)
Notice of Special Interest (NOSI): High-Priority Interest to Enhance Data Science Research Training in Addiction Research

About Us

The Population Aging Research Center (PARC) at the University of Pennsylvania has over 25 years of experience of creating the right setting for interdisciplinary research on the demography and economics of aging, including a focus on diverse and often underrepresented populations domestically and globally. The Population Aging Research Center (PARC) was established in 1994 with a grant from the National Institute on Aging. PARC sponsors an annual pilot proposal competition, a weekly seminar series in conjunction with the Population Studies Center, the Penn Population Studies Colloquium and an online working paper series, the Population Center Working Papers (PSC/PARC). The overall research themes of PARC reflect the interests and expertise of our research associates. These include: Health Care and Long-Term Care in Older Adults, Cognition and Alzheimer's Disease and Related Dementia (ADRD), Health Disparities in Aging, Early Life-Conditions and Older Adult Health, Behavior and Well-Being, and Global Aging and Health.

Quick Links

IRB & Human Subjects
NIH Public Access Policy
PSC Library Catalog
Sociology Department
Economics Department
DONATE TO THE PSC

Request Services

Reserve the PSC Conference Room and/or Collaboration Space
Submit a Working Paper/Brief
Submit News & Events

About Us

The Population Aging Research Center (PARC) at the University of Pennsylvania has over 25 years of experience of creating the right setting for interdisciplinary research on the demography and economics of aging, including a focus on diverse and often underrepresented populations domestically and globally. The Population Aging Research Center (PARC) was established in 1994 with a grant from the National Institute on Aging. PARC sponsors an annual pilot proposal competition, a weekly seminar series in conjunction with the Population Studies Center, the Penn Population Studies Colloquium and an online working paper series, the Population Center Working Papers (PSC/PARC). The overall research themes of PARC reflect the interests and expertise of our research associates. These include: Health Care and Long-Term Care in Older Adults, Cognition and Alzheimer's Disease and Related Dementia (ADRD), Health Disparities in Aging, Early Life-Conditions and Older Adult Health, Behavior and Well-Being, and Global Aging and Health.

Contact

Tel: 215-898-6441
Fax: 215-898-2124

239 McNeil Building
3718 Locust Walk
Philadelphia, PA 19104-6298
[Map & Directions]

twitter.com/pennparc

facebook.com/pennpsc

Penn A-Z - Penn Calendar

© 2021 The Trustees of the University of Pennsylvania

Population Aging Research Center